NCIt definition : A polyethylene glycol (PEG)-conjugated mutein form of the cytokine interleukin-2 (IL-2),
with potential and specific activity on enhancing proliferation, survival and anti-tumor
activity of engineered orthoIL-2Rb-expressing CAR T-cells. Upon subcutaneous administration,
pegylated orthogonal (ortho) IL-2 STK-009 specifically targets and binds to mutated
orthoIL-2Rbeta (hoRbeta; hoRb) that is specifically expressed on certain engineered
CAR T-cells. This induces selective proliferation, survival, and cytotoxic function
of orthoIL-2Rbeta-expressing CAR T-cells, which enhances tumor cell killing and decreases
tumor cell proliferation. Pegylation of IL-2 protects the cytokine from degradation.
STK-009 does not bind to the wild type (WT) IL-2b receptor and does not activate IL-2-mediated
signaling in bystander T- and NK-cells, thereby limiting systemic toxicity.;